Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02787434 · ClinicalTrials.gov registry record · NA

Addressing Prostate Cancer Information Disparities With eHealth Technology

A NA study of Prostate Neoplasm, sponsored by Tufts University.

Completed
Registry status
NA
Development phase
125
Enrollment target
2
Study locations

NCT02787434 is a NA study of Prostate Neoplasm that has completed, run by Tufts University. The registered enrollment target is 125 participants, below the 1,116-participant average among 9 other Prostate Neoplasm trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02787434, a NA study of Prostate Neoplasm, has completed, sponsored by Tufts University.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
2
Study locations

Study Summary

This is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that will empower them to take part in decision-making regarding prostate cancer screening (PCS). The Prostate Cancer Screening Preparation (PCSPrep) tool was designed with intend to be delivered in primary care settings with attention to patient/provider interaction. Funding for this study comes from the National Institute of Health/National Cancer Institute (1R21CA178296).

Conditions Studied

Interventions

  • OTHER Prostate Cancer Screening Decision Aid

Study Locations (2)

Massachusetts

  • Tufts University - Medford

Virginia

  • Emory University Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2014-08
Est. Completion 2016-10
Phase NA

Sponsor

Tufts University

163 total trials

What the Registry Record Tells You About NCT02787434

The ClinicalTrials.gov registry entry for NCT02787434 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,116-participant average among 9 other Prostate Neoplasm trials with a reported enrollment target (89% lower). The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Prostate Cancer Screening Decision Aid is the first listed.

NCT02787434 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Virginia.

Frequently Asked Questions

What is clinical trial NCT02787434 about?

NCT02787434 is a clinical study titled "Addressing Prostate Cancer Information Disparities With eHealth Technology". This is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that will empower them to take part in decision-making regarding prostate cancer screening (PCS). The Prostate Cancer S...

What is the current status of trial NCT02787434?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2014-08. Estimated completion is 2016-10.

What conditions does trial NCT02787434 study?

This clinical trial studies the following conditions: Prostate Neoplasm.

What interventions are being tested in trial NCT02787434?

The interventions under investigation include: Prostate Cancer Screening Decision Aid (OTHER).

Who is sponsoring clinical trial NCT02787434?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02787434 being conducted?

This trial has 2 study locations across Massachusetts, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.